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Abstract
Background: Data comparison between SEER and EUROCARE database provided evidence that
colorectal cancer survival in USA is higher than in European countries. Since adjustment for stage
at diagnosis markedly reduces the survival differences, a screening bias was hypothesized.
Considering the important role of primary care in screening activities, the purpose of the study was
to investigate the colorectal cancer screening awareness among Hellenic physicians.
Methods: 211 primary care physicians were surveyed by mean of a self-reported prescription-
habits questionnaire. Both physicians' colorectal cancer screening behaviors and colorectal cancer
screening recommendations during usual check-up visits were analyzed.
Results: Only 50% of physicians were found to recommend screening for colorectal cancer during
usual check-up visits, and only 25% prescribed cost-effective procedures. The percentage of
physicians recommending stool occult blood test and sigmoidoscopy was 24% and 4% respectively.
Only 48% and 23% of physicians recognized a cancer screening value for stool occult blood test
and sigmoidoscopy. Colorectal screening recommendations were statistically lower among
physicians aged 30 or less (p = 0.012). No differences were found when gender, level and type of
specialization were analyzed, even though specialists in general practice showed a trend for better
prescription (p = 0.054).
Conclusion: Contemporary recommendations for colorectal cancer screening are not followed
by implementation in primary care setting. Education on presymptomatic control and screening
practice monitoring are required if primary care is to make a major impact on colorectal cancer
mortality.
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Background
Data comparison between EUROCARE and SEER data-
base provided evidence that colorectal cancer survival in
United States of America is higher than in European coun-
tries [1]. Survival differences were maintained irrespec-
tively of which European Nation was compared, and were
much higher when Eastern European countries were con-
sidered [1]. Correction for stage at diagnosis consistently
reduced survival differences and the reduction was sub-
stantially unrelated to the European geographic area ana-
lyzed [2]. The presence of a diagnostic colorectal cancer
screening bias was therefore hypothesized since early
diagnostic procedures might be much less available in
Europe than in USA [2]. Deficiencies in European colorec-
tal cancer screening guideline implementation, and inad-
equacy of screening test advising in primary care setting
were highlighted in a recent systematic review of litera-
ture, but only data from Italian and French physicians
were available for the USA vs European data comparison
[3].
Colorectal cancer screening survival benefit had been
strongly documented by randomized-controlled trials [4-
8] and a meta-analysis [9]. In this setting, time to diagno-
sis and, more precisely, stage at surgery, play the major
role for patient outcome. In addition to detecting early
stage cancers, screening can detect pre-cancerous polyps as
well, which can be removed, thereby preventing cancer.
Colorectal cancer screening is therefore strongly recom-
mended. Currently guidelines generally include: stool
occult blood test (SOBT) yearly and sigmoidoscopy every
3–5 years, both beginning at the age 50 [10-13]. There are
two major ways to implement these recommendations:
organized screening programs principally endorsed with
active invitations by the national health services; and
opportunistic screening recommendation by general prac-
titioners. Despite organised screening programmes are
based on a more coherent structure, offering a standard-
ised system of care and are at a recognized better level of
evidence, National CCS (colorectal cancer screening) pro-
grams are actually at the beginning in European countries,
and the ongoing pivotal experiences such as the Italian
(region-wide programs), UK and Finnish (started in 2000,
2001 and 2004 respectively) are too recent to impact on
survival [14-16]. Consequently, up to date opportunistic
screening implementation in European primary care set-
ting was mandatory. Indeed, physicians involved in pri-
mary care both implement programs with active
invitation [17] and recommend screening tests where
invitation programs are lacking. This is of particular
importance in Greece where organized colorectal cancer
screening programs are totally absent.
Since primary care physicians have a key role in screening
practice, and considering that little is known about their
screening recommendations in Europe [3], we surveyed a
random sample of Hellenic physicians employed in pri-
mary care activities. Both physicians' colorectal cancer
screening behaviors and colorectal cancer screening rec-
ommendations during usual check-up visits were ana-
lyzed.
Methods
The Hellenic trial
This study is part of a large ongoing program of research
on cancer screening practice in Greece, which is organized
by the PACMeR (Panhellenic Association for Continual
Medical Research). The study's aim is to indicate the cur-
rent rate of cancer screening among the Hellenic adult
population and to identify possible barriers to early diag-
nosis. In PACMeR_03 trial a medical questionnaire for
face-to-face interview was employed to investigate pri-
mary care physicians' screening prescriptions habits. The
project was approved by PACMReR's Scientific Commit-
tee and conformed to the ethical guidelines of the 1975
Declaration of Helsinki.
Enrollment
From August 2001 to December 2002, 600 medical doc-
tors employed in primary care activities were recruited
from medical lists of 14 health centers, 16 general hospital
and 31 rural ambulatory departments in 9 Hellenic prov-
inces (Achaia, Attikis, Chania, Cephalonia, Drama, Etolo-
carnania, Evro, Lesbo, Serres) and were invited to answer
the prescription-habits questionnaire in a self-reported
and nominal form during a face to face interview with a
PACMeR physician. Personal data privacy was warranted
for all physicians who refused to enter the trial.
Two hundred eleven (211) physicians agreed to partici-
pate: 105 male, 94 female, 12 did not declare gender (pri-
vacy was guaranteed in spite of the face-to-face nature of
the survey). The mean age of physicians involved in the
study was 34 (24 – 62 years old); 31 were specialists in
General Medical Practice (GMP), 22 trainees in GMP, 25
Internists, 53 trainees in Internal Medicine (employed in
internal medicine ambulatory department with activities
overlapping primary care), 78 unspecialized physicians
(employed in the compulsory rural primary care medical
service), 1 who did not answer this item.
Medical questionnaire
Physicians were invited to answer two main questions:
one for usual screening practice and one for specifically
indicated cancer screening practice.
1st Question: "When a patient older than 50 years old
comes to your office and asks for a general check up what
do you recommend?"BMC Gastroenterology 2006, 6:18 http://www.biomedcentral.com/1471-230X/6/18
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2nd Question: "Which of the following examinations do
you think should be prescribed to people older than 50
for cancer screening practice?"
The medical questionnaire contained a board of multiple
choices for 58 possible (related or unrelated) screening
procedures (i.e. digital rectal examination, chest radiogra-
phy, Papanicolaou smear, urinalysis, urinary culture,
prostate specific antigen).
For the 2nd Question the prescription frequency (monthly,
twice a year, yearly, every 2 years, 3 years, 5 years and no
prescription) should have been specified. Data obtained
were further analyzed for sigmoidoscopy, stool occult
blood test and digital rectal examination.
Due to the phrasing of the two questions, and considering
that DRE may be implemented for both colorectal and
prostate cancer screening, the determination of the imple-
mented proportion of the test in each setting was not pos-
sible, and related analysis should be therefore considered
a secondary outcome.
Subgroups analysis and statistics
Since it might be guessed that trainees and recently trained
physicians would be more likely to be aware of evidence-
based and cost-effectiveness studies, screening habits were
further analyzed for physicians' subgroups by age, sex,
level and type of specialization. Since the digital rectal
examination is not a cost effective screening procedure,
we considered its prescription of not value [18]. Colorec-
tal cancer screening habits were therefore divided in two
categories: no prescription OR prescription of at least one
documented cost-effective test (sigmoidoscopy or stool
occult blood test) at any frequency. Statistical analysis was
performed using Pearson's Chi-square test and Fisher's
exact test.
Results
We found that the 50% (106/211) of physicians recom-
mended colorectal cancer screening during usual check-
up visits. After exclusion of non-cost-effective screening
procedure (digital rectal examination) from the analysis,
the percentage of physicians recommending colorectal
screening (stool occult blood test and/or sigmoidoscopy)
shrank to 25% (52/211). Only the 3% (7/211) of physi-
cians was found to recommend both sigmoidoscopy and
fecal occult blood test; while the 1% (2/211) advised sig-
moidoscopy alone and the 20% (43/211) fecal occult
blood test alone.
When physicians were specifically asked about which
examinations they think should be prescribed to people
older than 50 for cancer screening practice, only the 77%
recognized a value for colorectal cancer screening tests
(any prescription considered: stool occult blood test and/
or sigmoidoscopy and/or digital rectal examination). This
percentage dropped to 53% (112/211) when only cost-
effective procedures were considered (stool occult blood
test and/or sigmoidoscopy). In this setting, we found that
18% (39/211) of physicians think that both sigmoidos-
copy and stool occult blood test should be prescribed for
cancer screening activities, while 4% (9/211) recom-
mended sigmoidoscopy alone, and 30% (64/211) for
stool occult blood test alone. Frequencies by which physi-
cians prescribe the abovementioned tests for screening
purposes are reported in Table 1.
Subgroups analysis
The colorectal cancer screening recommendations rate
during usual check-up visits were markedly higher among
specialists in general medical practice (45.2%) even
though the difference was not statistically significant
(exact p = 0.054). It was quite homogeneous among the
other specialization subgroups (trainees in general medi-
cal practice 18.2%, internists 20%, trainees in internal
medicine 22,6% and doctors employed in the post-law
compulsory rural primary care medical service 20,5%).
Colorectal cancer screening recommendation rate during
usual check-up visits was statistically lower among physi-
cians aged 30 or less versus older ones (p = 0.012).
Table 1: Hellenic PCPhs' recommendations of colorectal tests for cancer screening activities:
Screening 
tests
twice a year % yearly % every 2 years 
%
every 3 years 
%
every 5 years 
%
Useful 
undefined 
frequency %
Not useful %
SIG 063671 7 7
SOBT 33 56 1 1 15 2
DRE 65 54 1 1 13 2
Abbreviations used:
PCPhs primary care physicians
SIG sigmoidoscopy
SOBT stool occult blood test
DRE digital rectal examination
% percentageBMC Gastroenterology 2006, 6:18 http://www.biomedcentral.com/1471-230X/6/18
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When cancer-screening behaviors were considered, we
found no belief differences among physicians' subgroups
for any of the analyzed parameters: specialization (exact p
= 0.749), age (p = 0.057), gender (p = 0.191).
Discussion
Little is known in peer-reviewed literature about colorec-
tal cancer screening recommendations in European pri-
mary care. Up to date only 4 surveys had been reported
(three from France and one from Italy) [19-23] and rela-
tive results had been recently analyzed in a systematic
review of literature [3]. Present study is therefore the first
report from Greece and from a third European nation.
In spite of the documented survival benefit from colorec-
tal cancer screening [4-9], regardless of its recommenda-
tion by health authorities [10-13], and in sharp contrast
with the high rate of CCS recommendation by US physi-
cians [24], the rate of CCS implementation was not satis-
factory in any of the European studies but one [21] and
particularly in the present survey (table 2). Indeed in
Ganry study (2004)[21] a significant higher rate of CCS
advising (95%) was observed in comparison with previ-
ous French reports (1996, 2003)[19,20]; this may be
explained by the fact that time from guideline implemen-
tation (1998 for France)[25], related medical education
and putting guidelines in to practice are sequentially time
dependent processes. In our trial 46% of physicians
screened their healthy patients with digital rectal examina-
tion during regular general practice activities. This per-
centage was notably higher (68%) when cancer-screening
purpose was considered. Surprisingly, recommendation
of this not evidence-based test had been previously
reported among French physicians [19,21]. Indeed,
despite the "myth" of digital-rectal examination is alive
among physicians, its implementation as screening proce-
dure is not cost effective [18] and therefore not recom-
mended by major authorities [10-13,26,27].
We further observed that a large proportion of physicians
did not consider cancer-screening practice as a part of the
periodic health examination (only 50% of physicians
advise it during usual check-up visits, while the 77%
believe it should be prescribed in case of cancer screening
activities). The more discomforting finding in our trial
was that only the 25% of the surveyed physicians recom-
mended evidence-based screening tests during usual
check-up visits.
These results might be in part explained by the actual
composition of the Hellenic health system. Indeed, to
date primary care services were mainly guaranteed by
non-specialized physicians employed in the post law
compulsory medical service (for free service supported by
the Health system) and by private family physicians (for
fee services); and secondarily by internal medicine ambu-
latory division of general hospital and by professional
funds (for free services). Thus, non-specialized young
physicians are the key of the actual Hellenic primary care
system. Therefore, the low rate of screening recommenda-
tion observed should not be surprising and explains par-
tially why in our study colorectal screening
recommendations were statistically lower among physi-
cians aged 30 or less. In fact we found that specialists in
general practice showed a trend for better prescription (p
= 0.054).
Fortunately, the newborn sanitary system is progressively
substituting the unspecialized post law physicians with
specialized GPs. The whole primary care composition, as
Table 2: European studies indexing primary care physicians' recommendations of colorectal cancer screening during general practice 
activities.
Author Physicians 
analyzed
CCS % SIG % SOBT % COL % DRE % Country
PACMeR## 211 50 4 24 NA 46 Greece
Garcia Giannoli 
19
1 6 3 6 504 203 8 F r a n c e
Denis B20 374 66 0# 44 6 NA France
Ganry 21 4 8 0 9 5 N A 8 31 01 7 F r a n c e
Federici 22 6 9 9 7 85 56 44 8 N A I t a l y
Abbreviations used:
## Presented report
# Data obtained from personal communication with the author
CCS Percentage of physicians recommending colorectal cancer screening practice
SIG sigmoidoscopy
SOBT stool occult blood test
COL colonoscopy
DRE digital rectal examination
% percentage
NA data not assessedBMC Gastroenterology 2006, 6:18 http://www.biomedcentral.com/1471-230X/6/18
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well as services provided, may consequently radically
change in next 5–10 years. We therefore hope that a spe-
cialized system will provide both the hopeful changes and
a cost-effective screening coverage.
Anyway, our study presents many limitations and may
not be applicable to the whole population of primary care
physicians. Firstly we have data of only 211 physicians.
Secondly, practices of responders may be systematically
different from those of non-responders; a high rate of
non-responders is anyhow common in this kind of cross-
sectional survey [28-30]. Finally, lack in the availability of
dedicated local endoscopic services may discourage physi-
cians in recommending screening test; something that was
not assessed in our study.
The Hellenic need of a new redefinition for the primary
care setting should not be considered a local phenome-
non. Poorly defined role of primary care physicians in
screening services delivery and the need of a new re-defi-
nition of primary care activities have been evidenced even
in a recent survey of English practitioners [31]; and screen-
ing data coming from French and Italian surveys were
quite discouraging too [19-23]. This may be in part attrib-
uted to the history of guidelines implementation in both
single Nation and European setting. Indeed, the date of
guideline release is of a great importance since their dis-
semination, their cultural re-elaboration and the process
of putting them into practice are time-dependent proc-
esses [3]. Actually in Greece there are not national guide-
lines for colorectal cancer screening and European
guidelines were first time implemented only in 2003 [10].
Conclusion
Since early diagnosis of colorectal cancer and stage of dis-
ease at surgery are crucial for patients' survival, we con-
clude that a huge work has to be done in Hellenic and,
more widely, in European primary care setting if screening
is to make a major impact on colorectal cancer mortality.
Need for national guideline implementation and contin-
ual medical education are imperatively highlighted.
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